Mutations in the gene coding for leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dominant Parkinson's disease. The pathological mutations have been associated with an increase of LRRK2 kinase activity, although its physiological substrates have not been identified yet. The data we report here demonstrate that disease-associated mutant LRRK2 cell toxicity is due to mitochondria-dependent apoptosis. Transient transfection of mutant LRRK2 leads to neuronal death with clear apoptotic signs. Soluble caspase inhibitors or the genetic ablation of Apaf1 protects cells from apoptotic death. Moreover, we explored the function of two protein domains in LRRK2 (LRR and WD40) and demonstrate that the lack of these protein domains has a protective effect on mitochondria dysfunctions induced by mutant LRRK2.

Iaccarino, C., Crosio, C., Vitale, C., Sanna, G., Carri', M.t., Barone, P. (2007). Apoptotic mechanisms in mutant LRRK2-mediated cell death. HUMAN MOLECULAR GENETICS, 16(11), 1319-1326 [10.1093/hmg/ddm080].

Apoptotic mechanisms in mutant LRRK2-mediated cell death

CARRI', MARIA TERESA;
2007-06-01

Abstract

Mutations in the gene coding for leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dominant Parkinson's disease. The pathological mutations have been associated with an increase of LRRK2 kinase activity, although its physiological substrates have not been identified yet. The data we report here demonstrate that disease-associated mutant LRRK2 cell toxicity is due to mitochondria-dependent apoptosis. Transient transfection of mutant LRRK2 leads to neuronal death with clear apoptotic signs. Soluble caspase inhibitors or the genetic ablation of Apaf1 protects cells from apoptotic death. Moreover, we explored the function of two protein domains in LRRK2 (LRR and WD40) and demonstrate that the lack of these protein domains has a protective effect on mitochondria dysfunctions induced by mutant LRRK2.
1-giu-2007
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore BIO/10 - BIOCHIMICA
English
Con Impact Factor ISI
Apoptotic Protease-Activating Factor 1; Apoptosis; Parkinson Disease; Neurons; Humans; Mitochondria; Cell Line, Tumor; Protein-Serine-Threonine Kinases; Protein Structure, Tertiary
Iaccarino, C., Crosio, C., Vitale, C., Sanna, G., Carri', M.t., Barone, P. (2007). Apoptotic mechanisms in mutant LRRK2-mediated cell death. HUMAN MOLECULAR GENETICS, 16(11), 1319-1326 [10.1093/hmg/ddm080].
Iaccarino, C; Crosio, C; Vitale, C; Sanna, G; Carri', Mt; Barone, P
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
HMG07.pdf

accesso aperto

Descrizione: Pdf lavoro finale
Licenza: Creative commons
Dimensione 581.15 kB
Formato Adobe PDF
581.15 kB Adobe PDF Visualizza/Apri

Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons Creative Commons

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/34809
Citazioni
  • ???jsp.display-item.citation.pmc??? 89
  • Scopus 169
  • ???jsp.display-item.citation.isi??? 158
social impact